Robert J. Weyant, MS, DMD, DrPH, serves as Associate Dean of Dental Public Health and Community Outreach, and professor and chair of the Department of Dental Public Health at the School of Dental Medicine. He is also an associate professor of epidemiology at the Graduate School of Public Health.
Weyant received a master's degree in public health in 1978 and a dental degree in 1982 from the University of Pittsburgh School of Dental Medicine. In 1991 he earned a doctoral degree in epidemiology from the University of Michigan.
Weyant is a former Navy Dental Officer and V.A. dentist. He has been a diplomate of the American Board of Dental Public Health since 1987, and also is a past president of the American Association for Public Health Dentistry. He currently serves on numerous local, state and national committees aimed at reducing oral health disparities, increasing the dental workforce and improving access to oral care.
Weyant's research involves basic and social epidemiological research related to oral health disparities. Presently he is PI or co-PI on several NIH-funded studies of oral disease etiology. He also directs the Center for Oral Health Research in Appalachia (COHRA) and oversees the joint degree program in public health.
Weyant was recently acknowledged as the inaugural recipient of the American Association for Dental Research/American Dental Association (AADR/ADA) Evidence-Based Dentistry Faculty Award. He is recognized with this award for his life-long contributions to evidence-based dentistry.
1976 | University of Pittsburgh | BS
1978 | University of Pittsburgh Graduate School of Public Health | MPH
1982 | University of Pittsburgh School of Dental Medicine | DMD
1991 | University of Michigan | DrPH
Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, Nirula R, Vercruysse GA, O'Keeffe T, Joseph B, Alarcon LH, Callaway CW, Zuckerbraun BS, Neal MD, Forsythe RM, Rosengart MR, Billiar TR, Yealy DM, Peitzman AB, Sperry JL; STAAMP Study Group. Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical Trial. JAMA Surg. 2020 Oct 5;156(1):11–20. doi: 10.1001/jamasurg.2020.4350. Epub ahead of print. Erratum in: JAMA Surg. 2021 Jan 1;156(1):105. doi: 10.1001/jamasurg.2020.5809. PMID: 33016996; PMCID: PMC7536625.
Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ, Adams PW, Daley BJ, Miller RS, Harbrecht BG, Claridge JA, Phelan HA, Witham WR, Putnam AT, Duane TM, Alarcon LH, Callaway CW, Zuckerbraun BS, Neal MD, Rosengart MR, Forsythe RM, Billiar TR, Yealy DM, Peitzman AB, Zenati MS; PAMPer Study Group. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315-326. doi: 10.1056/NEJMoa1802345. PMID: 30044935.
Guo X, Liu S, Sheng Y, Zenati M, Billiar T, Herbert A, Wang Q. ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing. Cell Rep. 2023 Jul 25;42(7):112733. doi: 10.1016/j.celrep.2023.112733. Epub 2023 Jul 6. PMID: 37421629; PMCID: PMC10691306.
Murthy P, Zenati MS, AlMasri SS, DeSilva A, Singhi AD, Paniccia A, Lee KK, Simmons RL, Bahary N, Lotze MT, Zureikat AH. Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic Cancer. J Natl Compr Canc Netw. 2023 Dec 27;22(1D):e237070. doi: 10.6004/jnccn.2023.7070. PMID: 38150819.
Zureikat AH, Beane JD, Zenati MS, Al Abbas AI, Boone BA, Moser AJ, Bartlett DL, Hogg ME, Zeh HJ 3rd. 500 Minimally Invasive Robotic Pancreatoduodenectomies: One Decade of Optimizing Performance. Ann Surg. 2021 May 1;273(5):966-972. doi: 10.1097/SLA.0000000000003550. PMID: 31851003; PMCID: PMC7871451.
Li SR, Guyette F, Brown J, Zenati M, Reitz KM, Eastridge B, Nirula R, Vercruysse GA, O'Keeffe T, Joseph B, Neal MD, Zuckerbraun BS, Sperry JL. Early Prehospital Tranexamic Acid Following Injury Is Associated With a 30-day Survival Benefit: A Secondary Analysis of a Randomized Clinical Trial. Ann Surg. 2021 Sep 1;274(3):419-426. doi: 10.1097/SLA.0000000000005002. PMID: 34132695; PMCID: PMC8480233.
AlMasri SS, Zenati MS, Desilva A, Nassour I, Boone BA, Singhi AD, Bartlett DL, Liotta LA, Espina V, Loughran P, Lotze MT, Paniccia A, Zeh HJ 3rd, Zureikat AH, Bahary N. Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma. Cancer Med. 2021 Oct;10(20):7233-7241. doi: 10.1002/cam4.4211. Epub 2021 Sep 24. PMID: 34559451; PMCID: PMC8525088.
Guo X, Liu S, Yan R, Nguyen V, Zenati M, Billiar TR, Wang Q. ADAR1 RNA editing regulates endothelial cell functions via the MDA-5 RNA sensing signaling pathway. Life Sci Alliance. 2021 Dec 30;5(3):e202101191. doi: 10.26508/lsa.202101191. PMID: 34969816; PMCID: PMC8739526.
AlMasri S, Zenati M, Hammad A, Nassour I, Liu H, Hogg ME, Zeh HJ, Boone B, Bahary N, Singhi AD, Lee KK, Paniccia A, Zureikat AH. Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer. JAMA Netw Open. 2022 Jun 1;5(6):e2218355. doi: 10.1001/jamanetworkopen.2022.18355. Erratum in: JAMA Netw Open. 2022 Jul 01;5(7):e2227318. doi: 10.1001/jamanetworkopen.2022.27318. PMID: 35737385; PMCID: PMC9227002.
Liu JB, Tam V, Zenati MS, Schwartz D, Ali A, Low CA, Smith LJ, Zeh HJ 3rd, Zureikat AH, Hogg ME. Association of robotic approach with patient-reported outcomes after pancreatectomy: a prospective cohort study. HPB (Oxford). 2022 Oct;24(10):1659-1667. doi: 10.1016/j.hpb.2022.04.008. Epub 2022 Apr 26. PMID: 35568654.
